FDA Brief

Warning letters Drugs

FDA warning letter to

Levity Inc. dba Levity

LowIssued Feb 20Posted Mar 3Center for Drug Evaluation and Research (CDER)

FDA warned Levity over misleading website claims for compounded semaglutide and liraglutide, including implying Levity made the drugs and that they were FDA-approved.

What happened

FDA reviewed Levity's website in December 2025 and found it offered compounded semaglutide and liraglutide products. The site showed labels with “Levity” on them, suggesting Levity was the compounder even though FDA says it is not, and it used claims comparing the products to Ozempic, Wegovy, and Saxenda. FDA said those claims were false or misleading and made the products misbranded.

What FDA found

  1. Website labels pictured with “Levity” imply Levity compounded the drugs, but FDA says it did not.

    FDCA § 502(a) [21 U.S.C. § 352(a)]; FDCA § 502(bb) [21 U.S.C. § 352(bb)]; 21 CFR § 201.1(h)(2)
  2. The website claim “The same ingredient as Ozempic® + Wegovy®” falsely implies FDA approval or evaluation.

    FDCA § 502(a) [21 U.S.C. § 352(a)]; FDCA § 502(bb) [21 U.S.C. § 352(bb)]
  3. The website claim “The power of Saxenda®” falsely implies FDA approval or evaluation.

    FDCA § 502(a) [21 U.S.C. § 352(a)]; FDCA § 502(bb) [21 U.S.C. § 352(bb)]
  4. Selling or shipping these misbranded drugs in interstate commerce is prohibited.

    FDCA § 301(a) [21 U.S.C. § 331(a)]

What FDA wants

FDA asks Levity to respond within 15 working days describing steps to correct the violations, including identifying who makes the compounded products, providing sample labeling, and fixing or removing the misleading website claims.

Who should pay attention

  • telehealth companies selling compounded GLP-1 drugs
  • compounders whose products are advertised by telehealth sites
  • marketing teams writing drug claims for compounded products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low